Literature DB >> 3731676

Response to furosemide in chronic renal insufficiency: rationale for limited doses.

D C Brater, S A Anderson, D Brown-Cartwright.   

Abstract

Patients with renal insufficiency often undergo therapy with large doses of loop diuretics. We tested the hypotheses that remaining nephrons respond normally to amounts of diuretic reaching them, and that more limited doses than are commonly used are sufficient to reach effective portions of the dose-response curve. In eight patients with creatinine clearance less than 20 ml/min/1.73 m2, the amount of diuretic causing half-maximal response was identical to that in normal subjects, but the maximal response expressed as fractional excretion of sodium was increased approximately 60%. The upper plateau of the dose-response curve was attained with single intravenous doses of furosemide, 120 to 160 mg. In conclusion, remnant nephrons appear to demonstrate an exaggerated response to furosemide. Because maximal response was attained with single intravenous doses of furosemide of 120 to 160 mg, there appears to be no need to administer larger single doses in such patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731676     DOI: 10.1038/clpt.1986.151

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  23 in total

1.  Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Response to furosemide during dehydration with and without naproxen pretreatment of kidney donors and renal transplant recipients.

Authors:  P A Sjöström; B G Odlind; M Hammarlund-Udenaes
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Pharmacodynamic and kinetic considerations on diuretics as a basis for differential therapy.

Authors:  H Knauf; E Mutschler
Journal:  Klin Wochenschr       Date:  1991-04-04

Review 4.  Diuretics in pediatrics : current knowledge and future prospects.

Authors:  Maria M J van der Vorst; Joana E Kist; Albert J van der Heijden; Jacobus Burggraaf
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 5.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 6.  Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy.

Authors:  H Knauf; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  The renin angiotensin aldosterone system and frusemide response in congestive heart failure.

Authors:  S Reed; P Greene; T Ryan; B Cerimele; U Schwertschlag; M Weinberger; J Voelker
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

8.  Furosemide disposition in patients on CAPD.

Authors:  U Martin; R J Winney; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

9.  A quantitative method of evaluating the diuretic response to furosemide in rats.

Authors:  R Hori; K Okumura; K Inui; T Shibata; T Kikkoji; A Kamiya
Journal:  Pharm Res       Date:  1988-11       Impact factor: 4.200

Review 10.  Torasemide in advanced renal failure.

Authors:  J Kindler
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.